Haleon PLC closed 7.49% short of its 52-week high of £4.18, which the company achieved on March 4th.

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

Haleon (NYSE:HLN – Get Free Report) last released its earnings results on Thursday, February 27th.The company reported $0.05 EPS for the quarter. Haleon had a return on equity of 14.76% and a ...

Arrowstreet Capital Limited Partnership bought a new stake in shares of Haleon plc (NYSE:HLN – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

In trading on Monday, shares of Haleon plc (Symbol: HLN) crossed below their 200 day moving average of $9.72, changing hands as low as $9.19 per share. Haleon plc shares are currently trading down ...

British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...

Canada Soccer and Haleon Canada announced a new multi-year partnership committed to promoting health and wellness on and off ...

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Two types and sizes of Robitussin cough syrup have been recalled, its maker announced Wednesday through the U.S. Food and Drug Administration, due to "microbial contamination." ...

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of £4.00. The company’s shares closed yesterday at p369.60.